FBInvestor
Stocks / Keryx Biopharmaceuticals
Institutional Ownership

Keryx Biopharmaceuticals

CUSIP 492515101COMMON STOCKQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon